What Arterial Plaque Actually Is

Atherosclerosis is the slow buildup of plaque inside the walls of your arteries. It doesn’t happen overnight. Over years, LDL cholesterol particles work their way into the arterial wall, trigger an inflammatory response, and attract immune cells. Calcium and fibrous tissue accumulate around the affected area.

The result is a plaque deposit that narrows the artery and reduces blood flow. But not all plaque is the same. Calcified, stable plaque is hard and fibrous. It’s been there a long time and isn’t going anywhere fast. Soft, unstable plaque is a different story. It has a thin fibrous cap over a lipid-rich core, and it’s the kind that ruptures, causing clots that lead to heart attacks and strokes.

That distinction matters a lot when you’re asking whether plaque can be “reversed.”

Atherosclerosis starts earlier than most people think.
Autopsy studies have found early-stage fatty streaks in the coronary arteries of teenagers. By the time a person reaches their 40s, some degree of plaque buildup is common even without symptoms.

Can You Remove Plaque Completely?

No. There is no treatment, drug, supplement, or dietary approach with imaging evidence showing complete removal of arterial plaque. When natural health advocates say a food or supplement “removes” or “unclogs” arteries, that claim is not supported by clinical imaging data.

This applies to vitamin K2, nattokinase, EDTA chelation therapy, and a long list of other popular recommendations. The calcification hypothesis behind vitamin K2 is biologically interesting. The idea that K2 shuttles calcium out of arterial tissue is plausible in theory. But there are no randomized controlled trials showing measurable regression of coronary calcification from dietary K2 intake. Interesting theory, no imaging proof.

EDTA chelation has been studied. The TACT trial showed modest effects in a diabetic subgroup, but the evidence is not strong enough to conclude it reverses plaque, and the mechanism remains disputed.

What the Research Actually Shows: Plaque Regression

While complete removal isn’t possible, something meaningful is: plaque regression. That’s a measurable reduction in plaque volume, documented by intravascular ultrasound (IVUS), a technique that images the inside of coronary arteries directly.

The ASTEROID trial, published in JAMA in 2006, is the clearest example.[1] Dr. Steven Nissen and colleagues used IVUS to measure plaque volume in patients taking high-dose rosuvastatin (40 mg daily). After about two years, they found a statistically significant regression in plaque volume. Not dramatic, but real. The average reduction was around 6.8% in total atheroma volume.

The REVERSAL trial, also from Nissen’s group, compared intensive statin therapy to moderate statin therapy.[2] The moderate-dose group showed continued plaque progression. The intensive-dose group showed no progression at all. Halting the process is a meaningful result, even without regression.

ASTEROID Trial Finding (JAMA 2006)
High-dose rosuvastatin produced measurable plaque regression in coronary arteries, with a 6.8% reduction in total atheroma volume over 24 months, as measured by intravascular ultrasound. This was the first trial to show significant regression with statin therapy alone.
[1]

What About Lifestyle Changes?

Dean Ornish’s research showed something striking: very intensive lifestyle changes can produce measurable plaque regression in small randomized controlled trials.[3]

The key word is intensive. Ornish’s program wasn’t a moderate diet tweak. It combined a near-vegan plant-based diet, aerobic exercise, stress management practices, and group support sessions. Patients in his trials changed almost everything at once. The 1998 JAMA study showed that after five years, participants in the intensive lifestyle group showed continued regression while the control group showed progression.

So lifestyle changes can work. But “eating more vegetables” or “cutting back on red meat” is not what produced those results. The intervention was closer to a full life overhaul.

Plaque Stabilization May Matter More Than Plaque Volume

Here’s something the “reversal” conversation often misses. A smaller plaque is not automatically safer than a larger one. What matters is the plaque’s structure.

Vulnerable plaque, the soft, lipid-rich, unstable kind, is what kills people. When the thin fibrous cap over that lipid core ruptures, it triggers a clot. That clot can block blood flow to the heart or brain within minutes. This is what causes most acute heart attacks.

Stabilizing plaque means making that cap thicker and more fibrous, so it’s less likely to rupture. Statins appear to do this. They reduce the inflammatory environment inside the plaque, which encourages the fibrous cap to strengthen. A patient might end up with a slightly smaller plaque that’s also structurally tougher. Both effects matter, and the second one may protect life more directly than the first.

The rupture risk isn’t about size.
Many heart attacks occur in arteries with plaques that weren’t large enough to significantly narrow blood flow before they ruptured. A plaque that narrows an artery by 40% but is soft and inflamed can be more dangerous than one that narrows it by 70% but is calcified and stable.

The Practical Bottom Line

The goal isn’t to “unclog” your arteries. That framing leads people toward false cures and away from what actually works.

The realistic goals are: stop plaque from growing, and make existing plaque less likely to rupture. Both of those are achievable. Intensive statin therapy has imaging evidence behind it. Extreme lifestyle intervention has some evidence behind it. Stopping smoking, controlling blood pressure, and managing blood sugar all reduce the inflammatory environment that drives plaque progression.

If you have early atherosclerosis, or risk factors that suggest you might, the conversation to have is with your cardiologist about what level of LDL reduction to target and whether imaging tests are appropriate for your situation.

The honest answer to “can you reverse clogged arteries?” is: you can slow or partially reduce plaque volume under intensive conditions, and you can stabilize vulnerable plaque. That’s not nothing. It’s actually quite a lot, if you do it.